Video Experimental Relacionado

Updated: Jun 22, 2025

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood

Published on: April 28, 2016

GLP-1 aumenta la saciedad preingestiva a través de los circuitos hipotálamicos en ratones y humanos

Kyu Sik Kim¹, Joon Seok Park¹, Eunsang Hwang²

¹Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.

Science (New York, N.Y.)

|June 27, 2024

Resumen

Los agonistas de los receptores de péptido 1 similares al glucagón (GLP-1RA) reducen la obesidad al mejorar la saciedad antes de comer. Este estudio identifica neuronas específicas en el hipotálamo que median este efecto, ofreciendo nuevos objetivos para los tratamientos de la obesidad.

Área de la Ciencia:

La neurociencia
Endocrinología
Enfermedades metabólicas

Sus antecedentes:

Los agonistas de los receptores de péptido 1 similares al glucagón (GLP-1RA) son medicamentos antiobesidad establecidos.
Los mecanismos exactos del sistema nervioso central que subyacen a la eficacia del GLP- 1RA no se comprenden completamente.

Objetivo del estudio:

Para aclarar las vías neuronales a través de las cuales los GLP-1RA inducen la saciedad preingestiva.
Identificar poblaciones neuronales específicas involucradas en la regulación del apetito mediada por GLP-1RA.

Principales métodos:

Administración de GLP-1RA a personas con obesidad y análisis de su saciedad subjetiva.
Análisis del tejido cerebral en humanos y ratones para localizar las neuronas que expresan el receptor GLP-1 (GLP-1R).
Manipulación optogenética y imágenes de calcio de las neuronas GLP-1R del hipotálamo dorsomedial (DMH) en ratones.
Investigando la interacción entre las neuronas DMH GLP-1R y las neuronas NPY / AgRP del núcleo arqueado.

Principales resultados:

La administración de GLP- 1RA aumentó la saciedad preingestiva en pacientes con obesidad.
Se identificaron neuronas GLP- 1R en el DMH, un área clave del hipotálamo.
La activación de las neuronas GLP-1R de DMH imitaba los efectos de saciedad.
Estas neuronas mostraron una mayor actividad durante el comportamiento alimentario después del tratamiento con GLP- 1RA.
Se estableció una conexión funcional entre las neuronas DMH^GLP-1 y ARC^NPY/AgRP que regulan la ingesta de alimentos.

Conclusiones:

Los GLP-1RA ejercen sus efectos antiobesidad mediante la modulación de la saciedad preingestiva a través de un mecanismo hipotalámico.
Las neuronas DMH^GLP-1 son críticas para codificar la saciedad preingestiva y mediar la acción de GLP-1RA.
La interacción entre las neuronas DMH^GLP-1R y ARC^NPY/AgRP representa un nuevo objetivo para las intervenciones contra la obesidad.

Más Videos Relacionados

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

Published on: May 24, 2018

Author Spotlight: Accessible M&M-Based Mouse Model for Investigating Binge Eating Disorder - Insights into Eating Behaviors, Anxiety, and Neural Mechanisms

Author Spotlight: Accessible M&M-Based Mouse Model for Investigating Binge Eating Disorder - Insights into Eating Behaviors, Anxiety, and Neural Mechanisms

Published on: January 10, 2025

Videos de Conceptos Relacionados

Regulation of Food Intake

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

Hormonal Regulation

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.

GPCRs Regulate Adenylyl Cylase Activity

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...